Mark R. Hake

Mark R. Hake

Mark R. Hake, CFA is a financial analyst and entrepreneur. He has been a Chartered Financial Analyst (CFA) for 31 years and has owned his own investment management and investment research firms that focused on value stocks, both in the U.S. and overseas.

Mark writes over 600 articles per year on stocks, cryptos, SPACs, convertibles, ETFs, and other financial securities. He has been ranked with 5 stars by TipRanks.com (under “Mark R. Hake”) with an average return of over 22% annually and #36 out of 8,116 writers. Presently he authors articles on Medium.com and other sites.

Mark also invests in public and private equities and has acted as a hedge fund manager and portfolio manager for various money management firms. He has also acted as CFO and Chief Strategy Officer for several fin-tech and software companies.

You can follow Mark on LinkedIn and on TipRanks.

Recent Articles

Novavax Stock Should Take Off as Its Successful Covid-19 Vaccine Spreads

Novavax should take off as its successful Covid-19 vaccine spreads. NVAX stock is worth at least 50% more, given a mixture of analysts’ estimates and comp analysis.

The Trade Desk Is Worth Almost 30% More Thanks to Huge Free Cash Flow

TTD stock is worth $98.13, given its gushing FCF margins and forecast digital ad growth. That makes it an interesting buy at these levels.

Pershing Square Tontine Holdings Trades Well Below the Sum of Its Parts

Pershing Square Tontine Holdings trades well below its sum-of-the-parts. PSTH stock is worth $30.50 on a SOTP basis, implying a 35% potential return for investors.

Opendoor Technologies’ Home Buying Spree Will Spike OPEN Stock

Opendoor Technologies’ home-buying spree will spike OPEN stock. OPEN stock is worth $23.84, up 39%, based on the company’s real estate revenue forecasts.

Castor Maritime’s Capital Raise Benefits the CEO and No One Else

The book value of CTRM stock has plummeted over 90% since the end of 2018, and the recent $300 million capital raise will make things worse.